These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

300 related articles for article (PubMed ID: 24203812)

  • 21. Innate immunity in diabetic kidney disease.
    Tang SCW; Yiu WH
    Nat Rev Nephrol; 2020 Apr; 16(4):206-222. PubMed ID: 31942046
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Immune Cells and Inflammation in Diabetic Nephropathy.
    Zheng Z; Zheng F
    J Diabetes Res; 2016; 2016():1841690. PubMed ID: 26824038
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Innate immune sensing of pathogens and danger signals by cell surface Toll-like receptors.
    Miyake K
    Semin Immunol; 2007 Feb; 19(1):3-10. PubMed ID: 17275324
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The Inhibitory Effect of Rapamycin on Toll Like Receptor 4 and Interleukin 17 in the Early Stage of Rat Diabetic Nephropathy.
    Yu R; Bo H; Villani V; Spencer PJ; Fu P
    Kidney Blood Press Res; 2016; 41(1):55-69. PubMed ID: 26849067
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Diabetic nephropathy - is this an immune disorder?
    Tesch GH
    Clin Sci (Lond); 2017 Aug; 131(16):2183-2199. PubMed ID: 28760771
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The role of Toll-like receptor proteins (TLR) 2 and 4 in mediating inflammation in proximal tubules.
    Mudaliar H; Pollock C; Komala MG; Chadban S; Wu H; Panchapakesan U
    Am J Physiol Renal Physiol; 2013 Jul; 305(2):F143-54. PubMed ID: 23576640
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Toll-like receptor signaling: a critical modulator of cell survival and ischemic injury in the heart.
    Chao W
    Am J Physiol Heart Circ Physiol; 2009 Jan; 296(1):H1-12. PubMed ID: 19011041
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Regulation of innate immune responses by Toll-like receptors.
    Takeda K; Akira S
    Jpn J Infect Dis; 2001 Dec; 54(6):209-19. PubMed ID: 11862002
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The role of innate immunity in diabetic nephropathy and their therapeutic consequences.
    Yang M; Zhang C
    J Pharm Anal; 2024 Jan; 14(1):39-51. PubMed ID: 38352948
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Pathogen recognition and Toll-like receptor targeted therapeutics in innate immune cells.
    Tartey S; Takeuchi O
    Int Rev Immunol; 2017 Mar; 36(2):57-73. PubMed ID: 28060562
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Histamine and diabetic nephropathy: an up-to-date overview.
    Pini A; Verta R; Grange C; Gurrieri M; Rosa AC
    Clin Sci (Lond); 2019 Jan; 133(1):41-54. PubMed ID: 30606813
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Toll-like receptors as sensors of pathogens.
    Hallman M; Rämet M; Ezekowitz RA
    Pediatr Res; 2001 Sep; 50(3):315-21. PubMed ID: 11518816
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Toll-like receptors: sensor molecules for detecting damage to the nervous system.
    Lee H; Lee S; Cho IH; Lee SJ
    Curr Protein Pept Sci; 2013 Feb; 14(1):33-42. PubMed ID: 23441900
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Roles of pattern recognition receptors in diabetic nephropathy.
    Zhou ZF; Jiang L; Zhao Q; Wang Y; Zhou J; Chen QK; Lv JL
    J Zhejiang Univ Sci B; 2020 Mar.; 21(3):192-203. PubMed ID: 32133797
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Toll-Like Receptors (TLRs) and their potential therapeutic applications in diabetic neuropathy.
    Aghamiri SH; Komlakh K; Ghaffari M
    Int Immunopharmacol; 2022 Jan; 102():108398. PubMed ID: 34863652
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Role of toll-like receptors in liver transplantation.
    Howell J; Gow P; Angus P; Visvanathan K
    Liver Transpl; 2014 Mar; 20(3):270-80. PubMed ID: 24243591
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Toll-like receptors: emerging concepts in kidney disease.
    Anders HJ; Schlöndorff D
    Curr Opin Nephrol Hypertens; 2007 May; 16(3):177-83. PubMed ID: 17420659
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Innate immunity and Toll-like receptor signaling in the pathogenesis of scleroderma: advances and opportunities for therapy.
    Brown M; O'Reilly S
    Curr Opin Rheumatol; 2018 Nov; 30(6):600-605. PubMed ID: 30234721
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effects of total glucosides of paeony on immune regulatory toll-like receptors TLR2 and 4 in the kidney from diabetic rats.
    Xu XX; Qi XM; Zhang W; Zhang CQ; Wu XX; Wu YG; Wang K; Shen JJ
    Phytomedicine; 2014 May; 21(6):815-23. PubMed ID: 24462407
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Innate immunity in systemic sclerosis pathogenesis.
    O'Reilly S
    Clin Sci (Lond); 2014 Mar; 126(5):329-37. PubMed ID: 24219159
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.